Literature DB >> 25610538

Role of radiotherapy in the pre-operative management of carcinoma of the esophagus.

Bryan H Burmeister1.   

Abstract

The use of radiotherapy in the management of carcinoma of the esophagus and gastro-esophageal junction has undergone much evolution over the past 2 decades. Advances to define its role have been slow with meta-analyses often providing the most useful data. In spite of this many institutions around the world are divided about the role of radiotherapy in this disease and attribute different roles to radiotherapy based on clinical stage, tumor site and histology. The purpose of this review is to try to define the role of radiotherapy given our current knowledge base and to review which current and future trials may fill the gaps of knowledge that we currently have. It will also highlight the difficulties in making firm recommendations about the use of radiotherapy especially in a time when technology and treatments are rapidly evolving.

Entities:  

Keywords:  Chemoradiotherapy; Esophageal cancer; Neoadjuvant therapy; Preoperative therapy; Surgery

Year:  2015        PMID: 25610538      PMCID: PMC4295172          DOI: 10.4251/wjgo.v7.i1.1

Source DB:  PubMed          Journal:  World J Gastrointest Oncol


  25 in total

1.  A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer.

Authors:  John D Urschel; Hari Vasan
Journal:  Am J Surg       Date:  2003-06       Impact factor: 2.565

Review 2.  Preoperative chemo(radio)therapy versus primary surgery for gastroesophageal adenocarcinoma: systematic review with meta-analysis combining individual patient and aggregate data.

Authors:  Ulrich Ronellenfitsch; Matthias Schwarzbach; Ralf Hofheinz; Peter Kienle; Meinhard Kieser; Tracy E Slanger; Bryan Burmeister; David Kelsen; Donna Niedzwiecki; Christoph Schuhmacher; Susan Urba; Cornelis van de Velde; Thomas N Walsh; Marc Ychou; Katrin Jensen
Journal:  Eur J Cancer       Date:  2013-06-22       Impact factor: 9.162

3.  The value of preoperative radiotherapy in esophageal cancer: results of a study of the E.O.R.T.C.

Authors:  M Gignoux; A Roussel; B Paillot; M Gillet; P Schlag; J P Favre; O Dalesio; M Buyse; N Duez
Journal:  World J Surg       Date:  1987-08       Impact factor: 3.352

4.  Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus.

Authors:  J F Bosset; M Gignoux; J P Triboulet; E Tiret; G Mantion; D Elias; P Lozach; J C Ollier; J J Pavy; M Mercier; T Sahmoud
Journal:  N Engl J Med       Date:  1997-07-17       Impact factor: 91.245

5.  A comparison of multimodal therapy and surgery for esophageal adenocarcinoma.

Authors:  T N Walsh; N Noonan; D Hollywood; A Kelly; N Keeling; T P Hennessy
Journal:  N Engl J Med       Date:  1996-08-15       Impact factor: 91.245

Review 6.  Preoperative radiotherapy for esophageal carcinoma.

Authors:  S J Arnott; W Duncan; M Gignoux; H S Hansen; B Launois; K Nygaard; M K B Parmar; A Rousell; G Spilopoulos; G Stewart; J F Tierney; M Wang; Z Rhugang
Journal:  Cochrane Database Syst Rev       Date:  2005-10-19

Review 7.  Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis.

Authors:  F Fiorica; D Di Bona; F Schepis; A Licata; L Shahied; A Venturi; A M Falchi; A Craxì; C Cammà
Journal:  Gut       Date:  2004-07       Impact factor: 23.059

8.  Pre-operative radiotherapy prolongs survival in operable esophageal carcinoma: a randomized, multicenter study of pre-operative radiotherapy and chemotherapy. The second Scandinavian trial in esophageal cancer.

Authors:  K Nygaard; S Hagen; H S Hansen; R Hatlevoll; R Hultborn; A Jakobsen; M Mäntyla; H Modig; E Munck-Wikland; B Rosengren
Journal:  World J Surg       Date:  1992 Nov-Dec       Impact factor: 3.352

9.  A single institutional phase III trial of preoperative chemotherapy with hyperfractionation radiotherapy plus surgery versus surgery alone for resectable esophageal squamous cell carcinoma.

Authors:  J-L Lee; S I Park; S-B Kim; H-Y Jung; G H Lee; J-H Kim; H-Y Song; K-J Cho; W-K Kim; J-S Lee; S-H Kim; Y-I Min
Journal:  Ann Oncol       Date:  2004-06       Impact factor: 32.976

10.  A randomized study of chemotherapy, radiation therapy, and surgery versus surgery for localized squamous cell carcinoma of the esophagus.

Authors:  E Le Prise; P L Etienne; B Meunier; G Maddern; M Ben Hassel; D Gedouin; D Boutin; J P Campion; B Launois
Journal:  Cancer       Date:  1994-04-01       Impact factor: 6.860

View more
  3 in total

Review 1.  Pre-operative treatments for adenocarcinoma of the lower oesophagus and gastro-oesophageal junction: a review of the current evidence from randomized trials.

Authors:  Pierfrancesco Franco; Francesca Arcadipane; Paolo Strignano; Rosella Spadi; Elisabetta Trino; Stefania Martini; Giuseppe Carlo Iorio; Maria Antonietta Satolli; Mario Airoldi; Renato Romagnoli; Michele Camandona; Umberto Ricardi
Journal:  Med Oncol       Date:  2017-02-07       Impact factor: 3.064

Review 2.  Esophageal cancer: The latest on chemoprevention and state of the art therapies.

Authors:  Gregoire F Le Bras; Muhammad H Farooq; Gary W Falk; Claudia D Andl
Journal:  Pharmacol Res       Date:  2016-08-24       Impact factor: 7.658

3.  Survival benefit of neoadjuvant versus adjuvant radiotherapy in lymph node positive esophageal cancer: a population based analysis.

Authors:  Nishitha Thumallapally; Ahmed Meshref; Mohammed Mousa; Mohamed Hendawi; Mei Lan; Ahmed I Salem; Frank Forte
Journal:  J Gastrointest Oncol       Date:  2017-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.